iMD Companies, Inc. Completes Expansion into Canadian Marketplace

iMD Companies, Inc. (OTC: ICBU) and its subsidiary Riize, LLC (Riize Health) have completed the target expansion into the Canadian marketplace. The Riize Health telemedicine platform has officially been approved and is now taking orders in Canada. The platform incorporates the same pharmaceutical and medical practitioner solutions that continue to produce dynamic growth in the U.S. for its sexual wellness product lines.

Riize Health's 100% online system provides discreet and secure access to licensed medical professionals for the assessment and prescribing of personal health products. In addition to the success of its core sexual wellness products, Riize Health anticipates adding a product line for Hair Growth in Q4, followed by products for TRT (Testosterone Replacement Therapy) and HRT (Hormone Replacement Therapy) in the coming weeks, further establishing itself as an innovative provider to the men's and women's personal health care market.

Having the ability to be an International Company and finalize the strategic launch in Canada with our amazing subsidiary Riize, enables iMD Companies to look at other International opportunities in the near future as well. Our product line expansion and entry into new markets is key to our revenue projections.